Sudeep Pharma Limited (NSE:SUDEEPPHRM)

India flag India · Delayed Price · Currency is INR
692.00
+8.20 (1.20%)
Apr 29, 2026, 3:05 PM IST
-5.21%
Market Cap 77.23B
Revenue (ttm) 6.17B
Net Income (ttm) 1.68B
Shares Out 112.95M
EPS (ttm) 15.40
PE Ratio 44.42
Forward PE 39.84
Dividend n/a
Ex-Dividend Date n/a
Volume 36,355
Average Volume 101,911
Open 694.00
Previous Close 683.80
Day's Range 685.10 - 694.95
52-Week Range 524.05 - 795.00
Beta n/a
RSI 65.68
Earnings Date Aug 19, 2026

About Sudeep Pharma

Sudeep Pharma Limited manufactures and sells excipients and specialty ingredients for the pharmaceutical, food, and nutrition industries in United States, Europe, United Kingdom, and Latin America. The company provides mineral salts, such as calcium, zinc, iron, potassium, magnesium, sodium, and copper to a range of health-focused applications; and calcium carbonate, which is used as an active pharmaceutical ingredient for various therapeutic applications. It also offers micronutrient premixes, encapsulated ingredients, liposomal and spray-drie... [Read more]

Sector Healthcare
Founded 1989
Employees 740
Stock Exchange National Stock Exchange of India
Ticker Symbol SUDEEPPHRM
Full Company Profile

Financial Performance

In fiscal year 2025, Sudeep Pharma's revenue was 5.02 billion, an increase of 9.30% compared to the previous year's 4.59 billion. Earnings were 1.39 billion, an increase of 4.14%.

Financial Statements

News

There is no news available yet.